Meloxicam Versus Ibuprofen for Pain Control After Third Molar Exodontia in Adult Patients
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-59
SponsorUniversidad Austral de Chile
About this trial
Third molar extraction is a common dental procedure, offently related with pain and swelling. The purpose of this study is to evaluate if Meloxicam has a better effect relieving pain after the extraction than Ibuprofen, one of the most common pain relieving drugs administered after this procedure.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
meloxicam 7,5mg
DrugComparison of analgesic efficacy of Meloxicam Vs Ibuprofen
Treatment groups
68 Participants
are divided into 2 treatment groupsGroup A: Group A control. IbuprofenActive comparator 1 intervention
Group B: Group B experimental. MeloxicamActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Meloxicam effectiveness for post-surgical pain control.
A visual analogue scale ranging from 0 points (no pain) to 10 points (intolerable pain) will be used to measure post-exodontic pain, and values will be recorded on a questionnaire.
Time frame
3 daysLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: